Pharmacology Division, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study, Panjab University, Chandigarh, India.
Basic Clin Pharmacol Toxicol. 2010 Jul;107(1):577-82. doi: 10.1111/j.1742-7843.2010.00537.x. Epub 2010 Jan 25.
Sesamol (SML) (Sesamum indicum, Linn, Pedaliaceae) has been used traditionally as a health supplement in India and other countries for a long time. It is a well-known antioxidant, currently being tried against several neurological disorders. The present study was designed to evaluate the potential of sesamol treatment against 3-nitropropionic acid (3-NP)-induced cognitive impairment and oxidative damage in striatal, cortex and hippocampal regions of the rat. The memory performance was assessed by Morris water maze and elevated plus maze paradigms. The oxidative damage was assessed by estimating the total glutathione, reduced glutathione, oxidized glutathione levels and glutathione redox ratio. Glutathione-S-transferase and lactate dehydrogenase enzymes were also measured in different brain areas. 3-NP significantly impaired memory performance as assessed in Morris water maze and elevated plus maze, which was significantly attenuated by sesamol (5, 10 and 20 mg/kg) pre-treatment. On the other hand, 3-NP significantly induced oxidative stress and depleted total glutathione, reduced glutathione, glutathione-S-transferase, lactate dehydrogenase enzyme levels and redox ratio in the striatum, cortex and hippocampal regions as compared to the vehicle-treated group. Sesamol pre-treatment restored oxidative defence possibly by its free radical scavenging activity as compared to the 3NP-treated group. The present study suggests that sesamol could be used as an effective agent in the management of Huntington's disease.
芝麻酚(SML)(芝麻,亚麻科)在印度和其他国家长期以来一直被用作传统的健康补品。它是一种众所周知的抗氧化剂,目前正在针对几种神经疾病进行试验。本研究旨在评估芝麻酚治疗 3-硝基丙酸(3-NP)诱导的大鼠纹状体、皮质和海马区认知障碍和氧化损伤的潜力。通过 Morris 水迷宫和高架十字迷宫范式评估记忆性能。通过估计总谷胱甘肽、还原型谷胱甘肽、氧化型谷胱甘肽水平和谷胱甘肽氧化还原比来评估氧化损伤。还在不同脑区测量谷胱甘肽-S-转移酶和乳酸脱氢酶酶。3-NP 显著损害了 Morris 水迷宫和高架十字迷宫评估的记忆表现,而芝麻酚(5、10 和 20mg/kg)预处理显著减弱了这种损害。另一方面,与载体处理组相比,3-NP 显著诱导了纹状体、皮质和海马区的氧化应激,耗尽了总谷胱甘肽、还原型谷胱甘肽、谷胱甘肽-S-转移酶、乳酸脱氢酶酶水平和氧化还原比。与 3-NP 处理组相比,芝麻酚预处理通过其自由基清除活性恢复了氧化防御。本研究表明,芝麻酚可用作亨廷顿病治疗的有效药物。